IMPAIRED SARCOPLASMIC RETICULUM (SR) function is a major characteristic of human heart failure, and it has been suggested to reflect, at least partially, the depressed Ca cycling in the cardiac myocyte. In human failing hearts, Ca uptake into the SR is depressed due to a decrease in sarco(endo)plasmic reticulum Ca-ATPase (SERCA) relative to its inhibitory protein phospholamban (PLB) (9, 19) , whereas Ca release from the SR is defective due to alterations in the opening probability of the ryanodine receptor (RyR) (20, 21) . Both events would lead to decreased SR Ca content and depressed cardiac function. Thus it would be desirable to devise cellular methods that may lead to enhanced SR Ca load and improved function.
A newly discovered histidine-rich, Ca-binding protein (HRC) has been shown to increase SR Ca storage capacity in neonatal rat myocytes (14) . This protein appears to be an additional component of the SR Ca release structure, composed of the RyR, calsequestrin (CSQ), triadin (TRI), and junctin (JNT) (18, 33) . HRC binds Ca (3, 11, 25) and has been proposed to be either in the lumen of the SR (10, 15, 18, 30, 31) or on the cytoplasmic surface of the SR (5, 6, 27, 28) . There is a single isoform of HRC, identified in rabbit skeletal, cardiac, and arteriolar smooth muscles (10, 24, 26, 28) . The deduced amino acid sequence of HRC reveals structural features that are analogous to CSQ, suggesting that HRC may play a similar role to CSQ during excitation-contraction coupling, as a Ca storage protein (18) . In addition, biochemical studies in skeletal muscle have shown that HRC associates with TRI in a Ca-dependent manner, implicating HRC to be involved in regulation of Ca release from the SR by an interaction with TRI (18, 27, 28) .
In this study, we assessed the protein levels of HRC in animal models of heart failure and in human heart failure and identified significant decreases compared with nonfailing hearts. To gain insight into the functional significance of altered HRC expression levels, we infected adult rat cardiac ventricular myocytes with a recombinant adenovirus that contains the full-length mouse HRC cDNA (mHRC). For the first time, we demonstrate that overexpression of HRC in adult rat cardiomyocytes results in increased SR Ca storage capacity, but this Ca is not available for release, resulting in depressed myocyte Ca kinetics and mechanics. Thus HRC may be an integral regulatory protein in the cardiac muscle Ca-cycling cascade.
EXPERIMENTAL PROCEDURES
Animal heart failure samples and donor and failing human heart samples. Animal model tissues were obtained from Dr. Jeff Molkentin [calcineurin (CN)-overexpressing mouse hearts (23)] and Dr. Gerald Dorn [G␣ q-overexpressing mouse hearts (7)]. Human tissues were obtained from four nonfailing donor and five failing left ventricles (LVs). Once in the laboratory, the tissue was cut in pieces, frozen in liquid N 2, and stored at Ϫ80°C. All tissue was homogenized in a buffer (pH 7.0) containing 50 mM potassium phosphate buffer, 10 mM NaF, 1 mM EDTA, 0.3 M sucrose, 0.3 mM PMSF, 0.5 mM DTT, and a cocktail inhibitor protease inhibitor tablet (Roche). According to the established linear range, animal (10 g) and human (20 g) homogenates were then subjected to SDS-PAGE and immunoblotted as described below. This investigation conformed with the National Institutes of Health Guide for the Care and Use of Laboratory Animals (NIH Pub. No. 85-23, Revised 1996) and with the principles outlined in the Declaration of Helsinki (32) .
Adult rat ventricular myocyte isolation and culture. Hearts from adult male Sprague-Dawley rats (8 wk old) were perfused with modified Krebs-Henseleit buffer (KHB; 118 mM NaCl, 4.8 mM KCl, 25 mM HEPES, 1.25 mM K 2HPO4, 1.25 mM MgSO4, 11 mM glucose, 5 mM taurine, and 10 mM butanedione monoxime; pH 7.4) for 5 min. Subsequently, hearts were perfused with an enzyme solution [KHB containing 0.7 mg/ml collagenase type II (263 U/mg), 0.2 mg/ml hyaluronidase, 0.1% BSA, and 25 M Ca] for 10 min. Then, 25 M Ca was added to the perfusion buffer, and hearts were perfused for 5 min. Subsequently, the Ca concentration in the perfusion buffer was raised to 100 M, and perfusion continued for 5 min. Finally, LV tissue was excised, minced, pipette dissociated, and filtered through a 240-m screen. Cells were harvested and resuspended in 1 mM Ca-KHB ϩ 1% BSA. After brief centrifugation, the cells were resuspended in 1.8 mM Ca-KHB ϩ 1% BSA, centrifuged briefly again, and resuspended in ACCT medium (DMEM containing 2 mg/ml BSA, 2 mM L-carnitine, 5 mM creatine, 5 mM taurine, 100 IU/ml penicillin, and 100 g/ml streptomycin). Cells were then counted and plated on laminin-coated glass coverslips or dishes.
Adenovirus-mediated gene transfer. Recombinant adenovirus HRC was generated by using the Adeno-X expression system kit as described before (14) . Two hours after isolation and culture, myocytes seeded on coverslips or dishes were infected with either mHRC adenovirus (AdHRC) or green fluorescent protein adenovirus (AdGFP) in diluted media, at a multiplicity of infection of 800, for 2 h before the addition of a suitable volume of culture media. Twenty-four hours later, the myocytes were washed in 1 mM Ca-KHB and harvested for quantitative immunoblotting, immunostaining, or use in the experiments outlined below.
Quantitative immunoblotting. Cultured myocytes were then harvested and lysed for 20 min at 4°C in lysis buffer [20 mM Tris ⅐ HCl (pH 7.5), 150 mM NaCl, 1% NP-40, 10% glycerol, 0.4 mM sodium orthovanadate, 10 mM sodium pyrophosphate, 10 mM sodium fluoride, 0.5 mM DTT, and 2 l/ml protease inhibitor cocktail]. The supernatants obtained after centrifugation at 8,000 g for 10 min were then used in subsequent experiments. Protein loading (6 -30 g) varied for each protein; however, a linear range was performed on each immunoblot to ensure that protein loading was within the linear range of detection. Protein samples were electrophoresed on 6% (RyR), 8% (TRI, HRC, CSQ), or 12% (JNT, PLB, SERCA, CSQ) SDS-polyacrylamide gels under reducing conditions and then transferred to nitrocellulose membranes (various transfer conditions per respective protein). Membranes were blocked with 5% nonfat milk in Tris-buffered saline for 1 h at room temperature and then incubated overnight at 4°C or at room temperature for 2-3 h with the respective primary antibody: RyR (Affinity Bioregents); TRI (Affinity Bioreagents); HRC (polyclonal rabbit anti-mouse HRC antibody, generous gift from Dr. Woo Jin Park); JNT (polyclonal rabbit anti-canine JNT antibody, generous gift from Dr. Larry Jones); PLB (Affinity Bioreagents); SERCA (homemade polyclonal rabbit anti-SERCA antibody); and CSQ (Affinity Bioreagents). Blots were then washed in Tris-buffered saline, incubated with horseradish peroxidase-conjugated secondary antibodies (Amersham Biosciences) for 1 h at room temperature, washed again, and subsequently developed using the ECL chemiluminescence detection kit (Amersham Biosciences) according to the manufacturer's instructions. Protein loading was normalized to endogenous CSQ levels, as CSQ levels were not altered in HRC-overexpressing myocytes.
Immunostaining. Twenty-four hours after cardiomyocytes (grown on coverslips) were infected with either AdGFP or AdHRC, the cells were washed with chilled PBS, fixed for 15 min in a 4% formaldehyde solution, immersed in 0.5% Triton X-100 solution at room temperature for 15 min, washed twice in chilled PBS (5-min washes), and blocked in 5% BSA solution (in PBS) at 37°C for 30 min. Subsequently, the cells were incubated with diluted polyclonal rabbit anti-mHRC antibody (1:500 in blocking solution) for 1 h at room temperature, washed four times with chilled PBS (5-min washes), incubated with Alexa Fluor 488-conjugated goat ␣-rabbit IgG (Molecular Probes) secondary antibody (1:500 in blocking solution) for 1 h at room temperature, and washed again four times with chilled PBS. Finally, the myocyte-covered coverslip was inverted onto a slide containing 10 l of Vectashield mouting media (VECTA), and immunofluorescence was analyzed.
Contractile parameter measurements. Myocytes that adhered to the coverslips were bathed in temperature (37°C)-equilibrated KHB containing 1 mM Ca for 20 min. The myocyte suspension was then placed in a Plexiglas chamber, which was positioned on the stage of an inverted epifluorescence microscope (Nikon Diaphot 200). Myocyte contraction was field stimulated by a Grass S5 stimulator (0.5 Hz, square waves), and contractions were videotaped and digitized on a computer. A video edge motion detector (Crescent Electronics) was used to measure myocyte length and cell shortening, from which the percent fractional shortening (%FS) {[(resting cell length Ϫ maximal cell shortening length)/resting cell length]ϫ100} and maximal rates of contraction and relaxation (ϮdL/dt) were calculated (4). To investigate the response of adult rat cardiomyocytes ovexpressing HRC to isoproterenol, a maximal concentration of isoproterenol (100 nM) was added to the KHB (including 1 mM Ca) in the Plexiglas chamber, and the above-mentioned measurements were repeated. All data were analyzed using software from Felix 1.1 Software (Photon Technology) and Ionwizard.
Intracellular Ca transient and SR Ca load measurements.
To obtain intracellular Ca signals, myocytes that adhered to coverslips were incubated with the AM form of fura-2 (2 M) for 20 min at room temperature and then resuspended in KHB containing 1 mM Ca. After four washes, the coverslip was mounted in a Plexiglas chamber containing 2 ml of fresh KHB (including 1 mM Ca), which was field stimulated to contract at 0.5 Hz between platinum wire electrodes. The fura-2 fluorescence was determined at room temperature using a Delta Scan dual-beam spectrofluorophotometer (Photon Technology) operating at an emission wavelength of 510 nm with excitation wavelengths of 340 and 380 nm. Baseline, amplitude (estimated by the 340-to-380-nm ratio), the time for 50% decay of the Ca signal, and the fast time constant of decay of the Ca signal were acquired. To assess SR Ca load, caffeine-induced Ca release was initiated by rapid application of 10 mM caffeine (in Ca-free KHB). All data were analyzed using software from Felix 1.1 Software (Photon Technology) and Ionwizard.
Statistics. All results are expressed as means Ϯ SE. ANOVA, followed by a Bonferroni multiple-comparison post test, was used to compare animal models of heart failure. Student's paired t-test was used to compare data between human donor and heart failure samples and between AdGFP and AdHRC groups in the isolated myocyte studies. Furthermore, animal-based data (not cell based) was used for statistical comparisons. In all analyses, P Ͻ 0.05 was considered statistically significant.
RESULTS
HRC expression in heart failure. To determine whether there are alterations in HRC levels in heart failure, hearts from animal models of heart failure and human failing hearts were processed in parallel and subjected to quantitative immunoblotting. In these experiments, CSQ was used as an internal standard to normalize protein loading, since CSQ levels have been shown to remain unaltered in heart failure (8) . Two well-characterized models of heart failure were used with cardiac-specific CN overexpression (23) and G␣ q overexpression (7) . HRC levels were significantly decreased (ϳ40 -50%) in both animal models of heart failure relative to wild-type (WT) mice (Fig. 1A) . It is interesting to note that compared with WT mouse hearts, there were no alterations in the expression levels of HRC in CSQ-overexpressing mouse hearts (data not shown), which develop hypertrophy but do not transition to heart failure (29) . We also examined the levels of HRC in biopsy samples from human nonfailing (n ϭ 4) and failing (n ϭ 5) hearts with dilated cardiomyopathy and observed that HRC levels were significantly reduced (ϳ17%) in failing hearts (Fig. 1B) . This suggests that a perturbation in the levels of HRC may have a potential role in heart failure.
HRC expression in adult rat myocytes infected with AdHRC. The efficiency of adenoviral gene transfer was evaluated in cultured adult rat myocytes with the use of AdGFP. Nearly 100% of myocytes appeared infected at 800 plaque-forming units/cell by 24 h (data not shown). In a similar manner, myocytes were infected with either AdGFP or AdHRC. The cell morphology was similar among noninfected, AdGFPinfected, and AdHRC-infected groups after 24 h of culture. To determine the expression level of HRC in adult rat myocytes infected with either AdGFP or AdHRC, we performed quantitative immunoblot analysis of cellular homogenates. The levels of HRC increased by 40% at 6 h and by 70% at 24 h post-AdHRC infection, documented by quantitative immunoblotting with a polyclonal antibody to mHRC (Fig. 2) . HRC migrated with an apparent molecular mass of ϳ130 kDa, which is much greater than its expected molecular mass (ϳ79,860 Da), consistent with previous observations (14) . Immunostaining with the anti-mouse HRC antibody in adult rat ventricular myocytes revealed a consistent labeling pattern across the length and depth of myocytes infected with either AdGFP or AdHRC (data not shown). The staining pattern was more pronounced in the AdHRC-expressing myocytes compared with the controls, confirming the increased expression of HRC in AdHRC-infected myocytes. Immunostaining with anti-CSQ was also performed in parallel to determine a pattern for SR protein staining in adult rat ventricular myocytes (data not shown). The anti-CSQ staining pattern was similar to the anti-mHRC pattern in AdGFP and AdHRC-infected myocytes, indicating that HRC was localized to the same compartment as CSQ.
Overexpression of HRC impairs contractility of adult ventricular cardiomyocytes. To investigate the functional significance of elevated HRC protein levels in adult rat ventricular cardiomyocytes, we analyzed myocyte contractility with video edge detection. Figure 3A shows overlapping representative contractility traces from AdGFP-and AdHRC-infected cardiomyocytes. HRC overexpression resulted in a marked (36%) decrease in %FS compared with AdGFP-infected myocytes (Fig. 3B) . Decreased %FS in AdHRC myocytes was accompanied by a significant deceleration in the rates of myocyte shortening (ϩdL/dt: 38%) and relengthening (ϪdL/dt: 33%) compared with AdGFP-infected myocytes (Fig. 3C) . The AdGFP-infected myocytes exhibited similar parameters to nontransfected cells. Thus overexpression of HRC significantly depresses adult rat myocyte contractile parameters.
Overexpression of HRC decreases intracellular Ca transients in adult ventricular cardiomyocytes. The decrease in contractile parameters reflected an attenuation of Ca transients, assessed with use of the fura-2 AM fluorescence indicator in cardiac myocytes. Figure 4A shows representative fluorescence ratios comparing AdHRC-and AdGFP-infected cardiomyocytes. The Ca transient amplitude (ratio of 340 to 380 nm) in Fig. 1 . Histidine-rich, Ca-binding protein (HRC) levels in human and animal models of heart failure (HF). A and B: quantitative immunoblotting of HRC in wild-type (WT), calcineurin (CN)-overexpressing, and G␣q-overexpressing mouse hearts (A) and HF and donor (D) human hearts (B). Four, eight, and sixteen micrograms were used as a linear range for mouse samples; a standard curve for human heart samples (10, 20, and 40 g) was determined on a previous blot, and 20 g was determined to be within the linear range. HRC levels were normalized to endogenous calsequestrin as an internal control. Values in CN and G␣q hearts are expressed relative to those in WT (1.0) hearts, which were processed on the same gels. Values for human samples are expressed as relative units compared with one of the donor hearts (1.0), which served as a control among all blots. For mouse samples, n ϭ 3; for human donor samples, n ϭ 4; for human heart failure samples, n ϭ 5. Each blot was repeated three times. Values are means Ϯ SE. *P Ͻ 0.05. (6 g) is shown. The HRC protein (indicated by an arrow) is overexpressed in AdHRC-infected myocytes by 1.7-fold compared with AdGFP-infected myocytes. Pooled AdGFP-transfected myocyte lysates were used as a linear range (2, 4, and 8 g), and protein levels were normalized to endogenous calsequestrin (CSQ) levels within the same blot. n ϭ 6 separate hearts, each repeated in triplicate. Values are means Ϯ SE. *P Ͻ 0.05. the HRC-overexpressing myocytes was significantly reduced by 31% (Fig. 4B) , the time to 50% decay was delayed by 29% (Fig. 4C) , and the efficiency of relaxation was increased by 21% (Fig. 4D ) compared with AdGFP-infected myocytes. Thus the impairment in cellular contractility was associated with attenuated cytosolic Ca-cycling kinetics in HRC-overexpressing myocytes.
Caffeine-induced Ca release is enhanced by HRC overexpression. To determine whether overexpression of HRC altered the SR Ca storage capacity, we measured caffeineinduced Ca release in the AdHRC-infected myocytes. Initially, cells were electrically stimulated at 0.5 Hz; stimulation was then quenched for 10 s while 10 mM caffeine (dissolved in Ca-free buffer) was rapidly added to the myocytes. Representative fluorescence ratios comparing AdGFP-and AdHRC-infected cardiomyocytes are shown in Fig. 5A . The amplitude of the caffeine-stimulated Ca transient in HRC-overexpressing cells was increased by 28% relative to AdGFP-infected myocytes (Fig. 5B) . The amplitude of the electrically evoked Ca transient, expressed as a percentage of the caffeine-evoked Ca transient, has been referred to as fractional Ca release and has been suggested to reflect the percentage of Ca stored within the SR that is released upon electrical stimulation (2) . In this study, fractional Ca release was reduced in HRC-overexpressing cells by 37% relative to AdGFP-expressing myocytes (Fig. 5C) . Thus, collectively, our observations indicate that overexpression of HRC in adult rat ventricular myocytes increases SR Ca storage but suppresses the release of available Ca from the SR.
Effect of isoproterenol on the contractility and Ca transients in HRC-overexpressing cardiac myocytes.
To test the effect of HRC overexpression on ␤-adrenergic responses, adult rat cardiomyocytes were stimulated with a maximum concentration of isoproterenol (100 nM). The contractile and Ca kinetic parameters of infected myocytes are shown in Fig. 6 . Isoproterenol stimulation resulted in enhancement of mechanics and Ca kinetic parameters in both AdGFP-and AdHRC-infected cardiac myocytes. However, the depressed basal contractile and Ca kinetic parameters in the HRC-infected myocytes remained significantly depressed even after maximal isoproterenol stimulation (Fig. 6, A and B) .
Levels of SR Ca-cycling proteins. To determine whether the observed effects on Ca handling and contractile parameters were due to overexpression of HRC alone or whether there were compensatory alterations in other SR proteins, the levels of the major SR Ca-cycling proteins were assessed by quantitative immunoblotting. The levels of SERCA and its inhibitory protein PLB remained unaltered (Fig. 7A ). In contrast, overexpression of HRC (1.7-fold) was accompanied by almost similar increases in the 92-kDa cardiac isoform of TRI (1.8-fold increase) and in JNT (1.4-fold increase), whereas the levels of RyR and CSQ remained unaltered (Fig. 7B) . This finding suggests that HRC overexpression is associated with alterations in the protein expression levels of at least two integral proteins involved in SR Ca release, JNT and TRI, which may contribute to the impairment of SR Ca cycling and myocardial contractility. 
DISCUSSION
Our findings indicate that the levels of HRC are significantly decreased in human and mouse models of heart failure. Because heart failure has been characterized by decreased SR Ca content and depressed cardiac function and because overexpression of HRC in neonatal rat myocytes significantly enhanced the SR Ca storage capacity (14), we hypothesized that overexpressing HRC in myoyctes may enhance SR Ca load and improve function. In contrast to our hypothesis, this study presents the first evidence that overexpression of HRC in adult rat ventricular cardiomyocytes is associated with increased SR Ca load but decreased SR fractional Ca release, resulting in attenuated amplitude of the Ca transient and depressed contractile parameters in adult rat ventricular myocytes as well as increased levels of TRI and JNT, two important SR Cahandling proteins.
The SR internal Ca store of cardiac cells has a limited capacity; thus replenishment of Ca from the cytosol is necessary during each cycle of excitation-contraction coupling, and any perturbation in SR Ca cycling has been suggested to have detrimental effects on contractile function (22) . HRC overexpression leads to an increased SR Ca load; however, because this SR Ca is bound by the excess amount of HRC, the quantal release of SR Ca is severely depressed, and this is associated with attenuation of single-cell Ca transients and cardiac contractility (Figs. 3 and 4) . As a result, the diminished cytosolic Ca levels during contraction would lead to an attenuation of SERCA Ca transport rates and diminished rates of relaxation. Strikingly, this study suggests that a modest increase in expression of HRC (1.7-fold) is associated with a more dramatic phenotype than a 20-fold overexpression of CSQ (29) . Importantly, even though the SR Ca pools are unresponsive to electrical stimulation in HRC-overexpressing myocytes, they are released upon caffeine application, similar to findings in CSQ-overexpressing myocytes (13, 29) . This may suggest a defect in the RyR release of Ca, possibly due to an alteration in the sensitivity of the Ca regulatory site on the RyR, associated with the increased SR Ca-buffering capacity in myocytes overexpressing HRC. Thus the present study provides the first evidence that HRC is a regulator of SR Ca release. Future studies in lipid bilayer preparations from models with altered HRC expression levels will provide information on the effects of HRC on RyR function.
Because we hypothesized there is a tight balance between the levels of proteins involved in SR Ca uptake, storage, and release and that selective overexpression of one protein in the complex may interrupt their tight balance and cause alterations of other proteins, we investigated the levels of SERCA, PLB, RyR, TRI, JNT, and CSQ. We discovered that overexpression of HRC did not affect the levels of the proteins regulating SR Ca uptake (SERCA and PLB) but was associated with upregulation of TRI and JNT, two junctional SR proteins that have been suggested to associate into a stable quaternary complex at the SR junctional membrane, regulating SR Ca release. Interestingly, the levels of the other two proteins, RyR and CSQ, postulated to be part of the quaternary complex with TRI and JNT, remained unaltered. In light of the novel finding that TRI and JNT levels are upregulated in HRC-overepressing adult rat ventricular myocytes, it is important to speculate what effect upregulation of these proteins may have on increased SR Ca load and the resulting attenuated Ca transients and decreased contractile parameters observed in these myocytes. Indeed, it is possible that overexpression of HRC alone may alter the conformation of the SR quaternary release complex and, therefore, cause inhibition of RyR channel function. However, a recent study has shown that cardiac myocytes isolated from TRI-1-ovexpressing mice (5-fold) are characterized by delayed rates of Ca transient decay as well as decreased rates of cell shortening and relengthening, suggesting that upregulation of TRI-1 impairs myocardial contractility (16) . In addition, cardiac myocytes isolated from JNT-overexpressing mice (24-to 29-fold) exhibit lower basal intracellular Ca concentrations (12) , whereas myocytes isolated from JNT-overexpressing mice (10-fold) show impaired relaxation parameters, although caffeine-induced Ca release was attenuated compared with WT mice (17) . Thus it is more likely that perturbation in the levels of TRI, JNT, and HRC coordinately contribute to the resulting abnormal Ca cycling and impaired contractility observed in AdHRC-infected adult rat myocytes.
Recently, HRC has been suggested to be an additional component of the SR quaternary structure involved in Ca release (18) and may play a similar role to CSQ in SR Ca storage (14, 18) . Furthermore, an interaction between HRC and TRI has been reported (18, 27, 28) , although the apparent cross-talk between the players in the SR Ca release complex has not been elucidated. Interestingly, overexpression of JNT was associated with downregulation of TRI protein levels (12, 17) and vice verca (16) , suggesting an important compensatory cross-talk, because the overall structures and interacting characteristics of JNT and TRI are similar (12, 32) . Furthermore, in CSQ-overexpressing mouse myocytes, TRI and JNT levels were reduced by 50%, relative to control (13) . Thus this is the first evidence suggesting that perturbation in the level of one of the proteins in the stable quaternary complex at the SR junctional membrane, HRC, results in upregulation of both TRI and JNT and that this is associated with increased SR Ca load, decreased SR fractional Ca release, and impaired contractility in adult rat ventricular myocytes. These data, taken together, suggest that proper formation of a quaternary molecular complex between RyR, TRI, JNT, CSQ, and HRC is imperative for efficient SR Ca release and, subsequently, for normal cardiac function. Furthermore, this is the first data implicating HRC in regulation of SR Ca release, apart from its role in SR Ca storage.
Indeed, Ca cycling in the cardiac myocyte is a complex process, and further elucidation of the proteins involved in Ca uptake, storage, and release is necessary to better understand the basic physiology and pathophysiology of the heart. However, our findings indicate that HRC may be a regulatory protein in the cardiac muscle SR Ca-release cascade and that perturbation in HRC levels could be a potential mechanism underlying cardiac dysfunction. Given the role of HRC in increasing the SR Ca load that is unavailable for release, it is possible that HRC levels are downregulated in heart failure as a compensatory mechanism to increase the amount of Ca released from the SR, in an attempt to enhance Ca cycling and cardiac function. However, it is also likely that HRC levels may be critical for proper SR Ca cycling and any alterations, such as decreases in human and experimental heart failure or increases such as in our rat cardiac myocytes, result in abnormal Ca cycling and cardiac dysfunction. Further investigation in HRC-overexpressing and HRC knockout mice is required to more extensively address HRC's additional binding partners in cardiac SR as well as its physiological and pathophysiological role in SR Ca cycling. Myocytes were isolated from rat hearts, and cells from each heart were infected with either AdGFP (n ϭ 6 hearts) or AdHRC (n ϭ 6 hearts) in separate experiments. Pooled cells from each heart (n ϭ 6) were then subjected to quantitative immunoblotting in triplicate. Protein loading varied among proteins; however, a linear range was performed on each immunoblot to ensure that protein loading was within the linear range of detection (not shown). The molecular mass (in kDa) ladder is provided as a reference point. A: SERCA, sarco(endo)plasmic reticulum Ca-ATPase; PLB, phospholamban. B: RyR, ryanodine receptor; TRI, triadin; CSQ; JNT, junctin. Values are means Ϯ SE. *P Ͻ 0.05.
